Search Results - Eva Colas

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Effect of live Salmonella Ty21a in Dextran Sulfate Sodium-induced Colitis by Arnold Berstad, Einar Kristoffersen, Eva Colás, Anne Marita Milde, Gunnar Nysoeter, Kari Erichsen

    Published in Drug Target Insights (2007-01-01)
    Get full text
    Article


  2. 2

    Enabling Metabolomics Based Biomarker Discovery Studies Using Molecular Phenotyping of Exosome-Like Vesicles. by Tatiana Altadill, Irene Campoy, Lucia Lanau, Kirandeep Gill, Marina Rigau, Antonio Gil-Moreno, Jaume Reventos, Stephen Byers, Eva Colas, Amrita K Cheema

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


  3. 3

    Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition by Asmerom T. Sengal, Vanessa Bonazzi, Deborah Smith, Cristian P. Moiola, Rohan Lourie, Rebecca Rogers, Eva Colas, Antonio Gil-Moreno, Sophia Frentzas, Naven Chetty, Lewis Perrin, Pamela M. Pollock

    Published in npj Precision Oncology (2023-12-01)
    Get full text
    Article


  4. 4

    BORA overexpression promotes epithelial–mesenchymal transition and metastasis in ovarian cancer: Unveiling a novel therapeutic target for advanced disease by Marta Barber, Ariadna Boloix, Alfonso Parrilla, Mariana Köber, Laia Avilés‐Domínguez, Nora Ventosa, Lidia del Carmen Ramírez‐Morales, Asunción Perez‐Benavente, Antonio Gil‐Moreno, Eva Colàs, Juan Morote, Miguel F. Segura, Olga Méndez, Anna Santamaria

    Published in Clinical and Translational Medicine (2025-04-01)
    Get full text
    Article


  5. 5

    MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists by Sergio Espinosa-Gil, Saska Ivanova, Elisenda Alari-Pahissa, Melek Denizli, Beatriz Villafranca-Magdalena, Maria Viñas-Casas, Idoia Bolinaga-Ayala, Andrés Gámez-García, Claudia Faundez-Vidiella, Eva Colas, Miguel Lopez-Botet, Antonio Zorzano, José Miguel Lizcano

    Published in Cell Death and Disease (2023-11-01)
    Get full text
    Article


  6. 6

    Corrigendum: FXYD5/Dysadherin, a biomarker of endometrial cancer myometrial invasion and aggressiveness: its relationship with TGF-β1 and NF-κB pathways by María José Besso, Marina Rosso, Lara Lapyckyj, Cristian Pablo Moiola, Cristian Pablo Moiola, María Laura Matos, María Florencia Mercogliano, Roxana Schillaci, Jaume Reventos, Eva Colas, Antonio Gil-Moreno, Antonio Gil-Moreno, Alejandra Wernicke, Roberto Orti, Mónica Hebe Vazquez-Levin

    Published in Frontiers in Oncology (2024-01-01)
    Get full text
    Article


  7. 7

    FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways by María José Besso, Marina Rosso, Lara Lapyckyj, Cristian Pablo Moiola, Cristian Pablo Moiola, María Laura Matos, María Florencia Mercogliano, Roxana Schillaci, Jaume Reventos, Eva Colas, Antonio Gil-Moreno, Antonio Gil-Moreno, Alejandra Wernicke, Roberto Orti, Mónica Hebe Vazquez-Levin

    Published in Frontiers in Oncology (2019-12-01)
    Get full text
    Article


  8. 8

    Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application by Carlos Casas-Arozamena, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Eva Diaz, Sara S Oltra, Cristian Pablo Moiola, Silvia Cabrera, Alexandra Cortegoso, Teresa Curiel, Alicia Abalo, Mónica Pamies Serrano, Santiago Domingo, Pablo Padilla-Iserte, Marta Arnaez de la Cruz, Alicia Hernández, Virginia García-Pineda, Juan Ruiz-Bañobre, Rafael López, Xavier Matias-Guiu, Eva Colás, Antonio Gil-Moreno, Miguel Abal, Gema Moreno-Bueno, Laura Muinelo-Romay

    Get full text
    Article


Search Tools: